Arachidonic acid (AA) directly activates protein kinases C (PKC) and may thereby serve as a regulatory signal during cell stimulation. The effect, however, requires a >20 M concentration of the fatty acid. We find that human polymorphonuclear neutrophils ( or PKC␦ fused to the reporter enhanced green fluorescent protein (EGFP) were studied. AA caused EGFP-PKC␤ translocation from cytosol to plasma membrane at >0.5 M, and EGFP-PKC␦ translocation from cytosol to nuclear and, to a lesser extent, plasma membrane at as little as 30 nM. We conclude that AA induces PKC translocations to specific membrane targets at concentrations 2-4 orders of magnitude below those activating the enzymes. These responses, at least as they occur in PMN, do not require changes in cell Ca 2؉ or oxygenation of the fatty acid. AA seems more suited for signaling the movement than activation of PKC.
Members of the AGC superfamily of kinases move about cells phosphorylating key proteins on serine and threonine. The execution of this movement, or translocation, from one cell compartment to another is crucial to the function of these kinases. Typically, signal pathways entrained by cell stimulation convert resident lipids to products that help guide these kinases to the substrates and milieus appropriate for their phosphorylating activity. One family of AGC kinases, the protein kinases C (PKC), 1 affects virtually all aspects of cell physiology. The family was first studied as a phosphorylating activity that developed during the rise in cytosolic Ca 2ϩ ([Ca 2ϩ ] i ) and formation of diacylglycerol (DG) attending cell stimulation. High [Ca 2ϩ ] i , it was found, caused PKC to move from a latent state in cytosol to plasma membranes. Upon attaching to plasmalemmal phospholipids, particularly phosphatidylserine, the translocated PKC engaged membranous DG and thereby became active. It is now known that human PKC exist as four subfamilies of 13 isoforms (1-4). Conventional PKC␣, ␤ I , ␤ II , and ␥ are sensitive to Ca 2ϩ and DG; novel PKC␦, ⑀, , and are sensitive only to DG; and atypical PKC and are sensitive to neither signal. A more distantly related group of , , and PKD-2 isoforms binds DG but is Ca 2ϩ -insensitive and may or may not translocate depending on cell type (5-7).
Many factors besides Ca 2ϩ , DG, and phospholipids influence the disposition of PKC. Various organelle-associated modulator, scaffold, or substrate proteins bind and thereby recompartmentalize and assist in activating PKC, often in an isoformspecific manner (1-4, 8 -18) . The phosphorylation of regulatory residues is prerequisite for PKC activity but also may alter their location (1-4, 6, 15, 19, 20) . Finally, unsaturated fatty acids (UFAs) share with DG the ability to activate PKC (21) . Unlike DG, they target most PKC isoforms and can operate in the absence of phospholipid or Ca 2ϩ cofactors (reviewed in Ref. 22) . Because UFAs likewise activate PKC in whole cells (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , arachidonic acid (AA) has been proposed to participate in signaling for activation of the enzymes. AA is the major UFA released during cell stimulation and among UFAs has high efficacy in activating PKC. It nonetheless achieves this activation only at Ն20 -100 M, levels unlikely to occur physiologically. On the other hand, UFAs also cause cells to translocate PKC. Observed mainly at UFA concentrations that activate PKC, this effect has been either ignored or viewed as consequential and secondary in importance to PKC activation (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . We show here that AA induces PKC translocation in polymorphonuclear neutrophils (PMN) and HEK 293 cells at concentrations 2-4 orders of magnitude below those reported to activate the enzymes. Based on the criterion of potency, AA is better suited as a translocating than activating signal for PKC. (33) (34) (35) . pPKC␦-EGFP was a gift from Prof. N. Saito (Biosignal Research Center, Kobe University, Kobe, Japan). Human PMN were suspended in a modified Hanks' balanced solution (33) ; HEK 293 cells were grown in Dulbecco's modified essential medium (DMEM) with streptomycin (100 g/ml) and penicillin (100 units/ ml), Ϯ 10% fetal calf serum. Where indicated, Hanks' buffer and DMEM were made 100 M in ascorbic acid plus sufficient NaOH to maintain a constant pH.
[ 3 H]PDB Binding-PMN (5 ϫ 10 6 ) isolated from human donor blood (33) were incubated in 1 ml of Hanks' buffer at 37°C for 15 min, equilibrated with 125 pM [ 3 H]PDB for 5 min, challenged with 1 l of ethanol or a UFA dissolved in ethanol, and centrifuged through 400 l of silicone oil. Cell pellets and supernatant fluids were counted for radioactivity. Results are expressed as fmol of total recovered radiolabel that are cell-associated. [ 3 H]PDB binding attains equilibrium within 1 min regardless of PDB concentration (125 pM-10 M) or PMN calcium status (34, 35) .
PKC Immunodetection-PMN (2.5 ϫ 10 8 ) in 5 ml of Hanks' buffer were incubated at 37°C for 20 min; challenged with 5 l of ethanol or UFAs in ethanol; diluted in 40 ml of 4°C Hanks' buffer; and centrifuged (400 g; 5 min; 4°C). Cells were suspended in 5 ml of isotonic saline, incubated for 5 min at 4°C with 2 mM diisopropylfluorophosphate, and washed twice in Hanks' buffer. Cells (2 ϫ 10 8 /ml) were suspended in Hanks' buffer containing 2 mM EGTA, 1 mM PMSF, 1 g/ml leupeptin, 10 M benzamidine, 10 M pepstatin, and 0.2 g/ml aprotinin. Suspensions were sonicated (4°C; 5 strokes (3 s) of a Heat Systems sonicator, setting of 2) and centrifuged (800 ϫ g for 10 min at 4°C) to remove unbroken cells, nuclei, and other debris. Supernatant fluid from the centrifugation was layered onto sucrose gradients and centrifuged (150,000 ϫ g for 30 min at 4°C) to obtain fractions enriched in cytosol, plasma membrane, and granule markers (36, 37) . Fractions were assayed for protein (Bio-Rad protein assay; BSA as standard) and stored in 10% glycerol (-70°C). Samples of defined protein mass, PKC standards, and prestained M r markers were resolved on 7% SDS-polyacrylamide gels and electrotransferred to polyvinylidene difluoride membranes. The membranes were washed three times in TBS-T (10 mM Tris-HCl, 100 mM NaCl, 0.1% Tween, pH 7.5), blocked for 1 h with 5% Carnation nonfat dry milk in TBS-T, and washed three times in TBS-T. After a 2-h incubation with primary antibody (1/200 in 3% BSA/TBS-T, 0.02% sodium azide), membranes were washed six times in 300 ml of TBS-T, incubated for 1 h with secondary antibody (1/2000 in 5% milk/ TBS-T), and washed three times in TBS-T. Blots were developed with enhanced chemiluminescence kits as instructed by the manufacturer. Individual bands were quantified with ImageQuant (Molecular Dynamics, Sunnyvale CA). In Situ PKC Translocation-Our two vectors encoded for human PKC␤ I and PKC␦ fused to EGFP. pPKC␤-EGFP was transformed in DH5␣-competent cells and grown on LB agar (kanamycin, 30 g/ml). Colonies were picked and expanded in LB medium (kanamycin, 30 g/ml). After isolation with Maxi-prep DNA isolation kits, DNA was digested with KpnI and BamI to yield a fragment running with the appropriate size (2027 base pairs) on 1% agarose gels. pPKC␦-EGFP was transformed in DH5␣-competent cells and plated on LB agar (ampicillin, 50 g/ml). Colonies were selected and expanded in LB medium (ampicillin, 50 g/ml). On reaching an absorbance of 0.4 AU (400 nm), cultures were treated with 170 g/ml chloramphenicol and grown overnight. Digestion of isolated DNA with HindIII gave appropriately sized fragments of 1400 and 5600 base pairs on agarose gels. HEK-293 cells (2 ϫ 10 5 cells on 35-mm poly-L-lysine-coated dishes) were transfected with 2 g of a vector using the Life Technologies, Inc. LipofectAMINE kit and protocol. Cells were grown for 10 -12 days in DMEM, 10% fetal calf serum with 700 g/ml gentamycin. Viable cells were diluted to single cells and expanded in DMEM, 10% fetal calf serum, 400 g/ml gentamycin. Final colonies, which expressed appropriate molecular weight proteins that reacted with antibody to EGFP and either PKC␤ I or PKC␦ on Western blots, were maintained in this medium and transferred to serum-free DMEM supplemented with insulin, transferrin, and selenium for 18 h. Cells were challenged while being monitored by fluorescent (excitation at 488 nm, emission at 510 nm) and Nomarsky optics with a Zeiss LSM-510 confocal laser scanning system.
Cell Toxicity-As little as a 20 M concentration of a UFA caused PMN to leak preloaded fura-2 or Quin2, leak cytosolic LDH, and take up trypan blue (assayed as in Ref. 34) . At 30 M, AA induced leakage of LDH and the two chromophores but only several minutes after the peak in PKC translocation responses; at Ն50 M, it caused leakage by 2 min of PMN challenge. 5,8,11,14,17-Eicosapentaenoic acid had these respective immediate and delayed effects at 20 and 30 M; 8,11,14-eicosatrienoic acid and 11,14,17-eicosatrienoic acid at 30 and 50 M; and 8,11-eicosadienoic acid at Ն100 M and Ն 100 M. Eicosanoic acid lacked these effects at 100 M. We restricted most PMN analyses to UFA concentrations Յ10-fold below the level in which each fatty acid caused delayed cytolysis. HEK-293 cells did not leak LDH or EGFP-PKC isoforms nor alter uptake of trypan blue in the presence of 100 M AA. We did note that AA, at Ն1-10 M, caused HEK 293 cells to round, shrink, and, mostly in EGFP-PKC␤-expressing transfectants, form blebs. Because resting cells had blebs that were only faintly fluorescent and therefore hard to capture in our reproductions, AA, by causing cytosolic EGFP-PKC␤ to attach to plasmalemma, may have highlighted preexisting blebs more than caused new bleb formation. In any case, the data indicate that AA produces morphology changes that are not due to overt alterations in plasma membrane integrity.
RESULTS

PDB Binding-[
3 H]PDB has been used to track PKC in astrocytoma cells (38) , macrophage tumor cells (29) , platelets (39) , and PMN (34, 40) . The label binds to DG receptors. In consequence, its association with cells rises as these receptors move from the cell interior to surface membrane (34, 38) . The top panels of Fig. 1 give the PDB binding of PMN exposed to a 100 nM concentration of the leukocyte chemotactic factor (CF) FMLP. Cells were loaded with 1 M Quin2 and incubated with 1 M EGTA plus 0 (Ca 2ϩ -fixed) or 1. did not stimulate PDB binding (data not shown), and LTB 4 , although it elicited the response in Ca 2ϩ -repleted and Ca 2ϩ -fixed PMN, differed from AA in having no effect on Ca 2ϩ -chelated PMN (34) . Moreover, PMN pretreated with LTB 4 had reduced or down-regulated PDB binding responses to a second LTB 4 challenge yet responded fully to AA (data not shown) and an inhibitor of AA oxygenases, nordihydroguaiaretic acid, failed to reduce responses to AA (Table I) . Finally, UFAs that are not substrates for lipoxygenases or cyclooxygenases stimulated PDB binding. Their potencies were inversely related to saturation level, with the saturated fatty acid, arachidic acid, being devoid of activity (Fig. 4) .
PMN pretreated with a DG receptor agonist, either PDB, PMA, or dioctanoylglycerol, bound PDB minimally and did not raise this binding in response to UFAs (Table I) . The same agents, when added 2 min after UFAs, reversed the rise in PDB binding by Ն95% within 0.5 min (data not shown). Sphinganine, which blocks PKC attachment to membranes, also inhibited responses to UFAs (Table I) . Thus, baseline as well as stimulated PDB binding is reversible and sensitive to a drug disrupting PKC-membrane interactions. We also observed that Ca 2ϩ -repleated PMN treated with 100 M ascorbic acid for 10 min increased the binding of [ 3 H]PDB by 10.5 Ϯ 2 fmol (mean Ϯ S.E. for three experiments) 2 min after challenge with 1 M AA. This value was 9.9 Ϯ 0.8 fmol for cells not treated with the antioxidant. Finally, UFAs increased the number of sites bound by PDB in whole cells but did not alter the K d for this binding or the number of sites detected in sonicated PMN (Table II) . We conclude that AA and other UFAs induce PMN to raise the number of receptors available to PDB. In achieving the effect, they do not require processing by oxygenases, [Ca 2ϩ ] i rises, the generation of reactive oxygen species, or, because dioctanoylglycerol blocked but never increased PDB binding (Table I), the endogenous formation of DG.
PKC in PMN-PMN express ␣, ␤ I , ␤ II , ␦, and but not several other PKC isoforms (25, 29, 30, (43) (44) (45) (46) (47) (48) (49) . We confirmed that PMN contain the former but lack ⑀, , , or isoforms (36, 37) . PKC␣, ␤ I , ␤ II , and ␦ localized mostly to cytosol with small amounts in plasmalemma and traces of PKC and ␦ in granule fractions of resting PMN. The antibodies used here had high isoform specificity except that PKC␤ I antibody cross-reacted with PKC␤ II . Given these findings and the toxicity of UFAs (see "Cell Toxicity" under "Experimental Procedures"), we focused on PKC␣, ␤ II , and ␦ in experiments on Ca ] i (bottom panels) as in Fig. 1 . Data are mean Ϯ S.E. for 5-8 experiments.
chelated PMN were challenged with AA and separated into membrane, granule, and cytosol fractions. Fractions were resolved by SDS-polyacrylamide gel electrophoresis, transferred to membranes, and probed for PKC. HEK 293 Cells-HEK 293 cells expressing EGFP-PKC␤ presented homogenous fluorescence in the cytosol; nuclei lacked fluorescence. On exposure to AA, cytosol fluorescence fell, whereas fluorescence at the cell periphery rose (Fig. 8, top two  rows) . Nomarsky optical analysis localized the latter fluorescence to surface membrane (Fig. 9, A-C) . These responses occurred at 30, 10, 1, and 0.5 M AA but not at 0.1 M AA. Cells exposed to 30 M AA exhibited visible changes at Յ8 min; maximal changes occurred by 20 min. At 10, 1, and 0.5 M, just detectable and maximal effects occurred by ϳ20 and 30, 30 and 40, or 30 and 45 min, respectively (Fig. 10) . In all cases, maximal responses followed detectable responses within 10 min and did not reverse over 60 min. Cells challenged with arachidic acid (30 M) had no change in fluorescence pattern over 60 min (data not shown). Finally, addition of an antioxidant, ascorbic acid (100 M), to the cell cultures for 10 min did not alter the EGFP-PKC␤ response to 1 or 10 M AA (data not shown).
Cells expressing EGFP-PKC␦ displayed homogeneous fluorescence in cytosol and, to a lesser extent, nucleus. AA caused declines in cytosolic and rises in perinuclear fluorescence but little or no change in nucleoplasm fluorescence (Fig. 8, bottom  two rows) . Concurrently with these changes, localized areas of the cell periphery gained fluorescent intensity. Fig. 9, E, F, H , and I, indicates that rises in the fluorescence intensity occurred specifically at nuclear and plasma membranes. Cells exposed to 0.1-30 M AA initiated, maximized, and reversed these changes by ϳ2, 8, and 14 min, respectively (Fig. 11) . For cells treated with a 30 or 50 nM concentration of the fatty acid, fluorescence increases in plasma and nuclear membrane occurred 2-4 min after challenge (Fig. 9, G-I) . Again, 30 M (29), induce PKC to translocate. Although the latter effect may be consequential to activating these enzymes, the two responses are separable. For example, a low level of phosphatidylserine or Ca 2ϩ causes PKC to attach to membranes in vitro whereas a higher level of either agent also activates the membrane-attached PKC (1-4, 50, 51) . The activating effect of AA on most PKC isoforms, including ␣, ␤ II , and ␦, reportedly requires at least 20 -100 M. Such extreme levels of the fatty acid can occur in vivo; microparticles shed by perturbed cells may stimulate PKC and PKC-dependent functions by delivering up to 100 M free AA to various target cells (31, 52) . Under most physiological conditions, however, AA occurs at levels below this. Cells responding to receptor agonists, in particular, are unlikely to propel cytosolic AA to levels engendering PKC activation. We find that Ն10 -100 nM AA causes PMN and HEK (Tables I and II) . In studies not shown, PMN were challenged for 2 min with 3 M AA or arachidic acid, diluted with 9 volumes of 4°C buffer, disrupted, and fractionated on Percoll gradients. The former but not the latter fatty acid caused significant falls in cytosol and rises in plasmalemma PDB receptors but no such change in granule, endoplasmic reticulum, or heavy Golgi fractions. Thus, AA-induced PDB binding responses involve the movement of PDB receptors from cytosol to plasmalemma. In sucrose gradient experiments, AA, but not arachidic acid, similarly caused PMN to decrease cytosol and increase membrane PKC␣, ␤ II , and ␦ (Fig. 5) . Although membranes isolated from the latter gradients contain not only plasmalemma but also Golgi, endoplasmic reticulum, and other organelles (36) , PKC translocation paralleled [ 3 H]PDB binding. We accordingly interpret sucrose gradient data as indicating that PKC moved mainly if not exclusively from cytosol to plasmalemma. We stress, however, that other PDB receptor-bearing proteins (PKC␤ I , chimerin, etc.) may and likely do contribute to PDB binding (41, 42) .
PDB binding responses to CFs were slowed in Ca 2ϩ -fixed and absent in Ca 2ϩ -chelated PMN (34, 35) (Fig. 1) . CFs, including FMLP, likewise have reduced ability to translocate various PKC isoforms in PMN deprived of Ca 2ϩ (43) . In marked contrast, AA caused prominent PBD binding and PKC␤ II , ␣, and ␦ translocation (Figs. 3 and 5-7 (34, 35) (Fig. 1) responses to CFs by enhancing the movement of Ca 2ϩ -sensitive PKC isoforms. On the other hand, the effect of AA on PDB proved largely indifferent to PMN Ca 2ϩ status (Fig. 3) (Figs. 5-7) , as well as CFs (43) or other receptor agonists (32) . It will be important to determine whether endogenous AA has a role in these receptor-driven translocations. Relevant to this, agents that block AA-releasing enzymes, phospholipases A 2 , have recently been found to inhibit interleukin 2 in stimulating T lymphocytes to translocate PKC activity (53) .
AA did not trigger PKC translocation as a result of its oxygenation. 5-HETE and LTB 4 , the major oxygenation products formed from AA by PMN, did not mimic the action of AA. Moreover, LTB 4 down-regulated PMN to itself but not AA (data not shown), nordihydroguaiaretic acid did not alter the action of AA (Table I) , and other UFAs stimulated PDB binding (Table  II and Fig. 4 Fluorescent fusion products have been used to monitor the movements of various PKC isoforms. In CHO cells, EGFP-PKC␦ localizes to cytosol and nucleoplasm (60, 61) ; ATP stimulates the label to shift to plasmalemma, whereas phorbol esters cause it to move to plasma or nuclear membranes (61, 62) . LLCPK-1 cells localize EGFP-PKC␦ to plasmalemma and do not translocate it in response to dopamine, although dopamine translocates other PKC isoforms (63) . EGFP-PKC␤ II localizes exclusively to cytosol in HEK 293 cells and moves to plasmalemma in less than 1 min of challenge by G proteincoupled receptor agonists (64) . These reports evidence that the location, as well as the direction and kinetics of EGFP-PKC␦ and ␤ II movements, varies with cell, isoform, and stimulus type. Other PKC isoforms show similar variability (60, 65) . Most relevant here, however, are reports on UFAs. In CHO cells, Ն200 M AA and oleic acid cause rapid, transient shifts in EFFP-PKC␥ from cytosol to plasma membrane, whereas 50 M AA causes a slow, sustained shift in cytosol EGFP-PKC⑀ to the perinuclear area (66, 67) . We are unaware of reports on the effect of UFAs on other EGFP-PKC isoforms. We show here that AA caused HEK 293 cells to translocate EGFP-PKC␦ from cytosol to the entire nuclear and limited portions of the plasma membrane (Fig. 9, D-I) . Responses occurred and reversed within minutes of exposure to Ն30 nM AA (Fig. 8 , bottom two rows, and Fig. 11 ). AA affected EGFP-PKC␤ differently, causing it to move from cytosol to plasma membrane (Fig. 9, A-C) . Unlike the EGFP-PKC␦ response to AA here or the EGFP-PKC␥ responses to Ն200 M AA in CHO cells (66) , EGFP-PKC␤ movements evolved slowly, did not reverse for 60 min, and occurred at Ն0.5 M AA in HEK 293 cells (Fig. 8, top two rows,  and Fig. 10 ). As found elsewhere (60 -68), then, the kinetics and direction of PKC translocation responses to a given agent are isoform-specific and may relate to the unique functions of each PKC isoform (1-4) . Interestingly, resting HEK 293 cells localized EGFP-PKC␦ to both the cytosol and nucleoplasm but localized EGFP-PKC␤ only to the cytosol. This allows for the possibility that PKC␦ may have a nuclear membrane-targeting motif that over longer periods aids its penetration into nuclei.
In conclusion, AA causes PMN and HEK 293 cells to translocate PKC␣, ␤ I , ␤ II , and ␦ at concentrations 2-4 orders of magnitude below those reportedly activating the enzymes. Because PKCs must be correctly compartmentalized in order to engage their cofactors and substrates, AA, as presented to cells by, for example, microparticles or released during stimulation, may serve to direct Ca 2ϩ -sensitive and Ca 2ϩ -insensitive PKC isoforms to proper membrane targets and thereby assist, modulate, or (when no Ca 2ϩ transient occurs) replace [Ca 2ϩ ] i signals. Indeed, exogenous AA and DG operate synergistically to stimulate PKC and PKC-dependent responses in whole cells (1) (2) (3) (4) and may similarly cooperate when formed endogenously. The effect of AA on the translocation of PKC, at least as it occurs in PMN, proceeds independently of [Ca 2ϩ ] i , DG production, and oxygenation to eicosanoids. The fatty acid may act directly, after acylation to CoA or glycerolipids, or by stimulating PKC phosphorylation, PKC binding proteins, or other signal pathways.
